Back to search results

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma

Abroad (travel likely)RecruitingPHASE2

Conditions

Asthma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Novartis Investigative Site, Rousse, Bulgaria

  • Novartis Investigative Site, Sevlievo, Bulgaria

  • Novartis Investigative Site, Sofia, Bulgaria

  • Novartis Investigative Site, Ibague, Tolima Department, Colombia

  • Novartis Investigative Site, Guatemala City, GTM, Guatemala

  • Novartis Investigative Site, Guatemala City, Guatemala

  • Novartis Investigative Site, Debrecen, Hajdu Bihar Megye, Hungary

  • Novartis Investigative Site, Budapest, Hungary

  • Novartis Investigative Site, Budapest, Hungary

  • Novartis Investigative Site, Eger, Hungary

  • Novartis Investigative Site, Kaposvár, Hungary

  • Novartis Investigative Site, Nagykanizsa, Hungary

  • Novartis Investigative Site, Szigetvár, Hungary

  • Novartis Investigative Site, Tarnów, Poland, Poland

  • Novartis Investigative Site, Lodz, Łódź Voivodeship, Poland

  • Novartis Investigative Site, George, Western Cape, South Africa

  • Novartis Investigative Site, Cape Town, South Africa

  • Novartis Investigative Site, Esplugues, Barcelona, Spain

  • Novartis Investigative Site, Sabadell, Barcelona, Spain

  • Novartis Investigative Site, Mérida, Extremadura, Spain

  • Novartis Investigative Site, Barcelona, Spain

  • Novartis Investigative Site, London, United Kingdom

  • Novartis Investigative Site, Stoke-on-Trent, United Kingdom

View source on ClinicalTrials.gov(opens in a new tab)